Clinical Trial Update: A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer [Phase 1]

View source ↗

Summary

Phase 1 safety and dose-finding study of PRL-02 Depot in men with advanced prostate cancer is currently recruiting, indicating early clinical development status…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer
• Castration-sensitive Prostate Cancer
• Prostate Cancer

Drugs mentioned

• PRL-02 Depot

Snippet

Sponsor: Astellas Pharma Global Development, Inc. | Conditions: Prostate Cancer, Metastatic Castration Resistant Prostate Cancer | Phase 1 | Status: RECRUITING